Tutorials
Translate Bio Inc logo

Translate Bio Inc

(Delisted) $ 37.36 0 (0%) 04:00 PM EST
P/E:
73.83
P/B:
6.82
Market Cap:
$ 2.82B
Enterprise V:
$ 2.21B
Volume:
-
Avg Vol (2M):
4.56M
Volume:
-
Market Cap $:
2.82B
PE Ratio:
73.83
Avg Vol (2-Month):
4.56M
Enterprise Value $:
2.21B
PB Ratio:
6.82
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Translate Bio Inc
NAICS : 325412 SIC : 2833
29 Hartwell Avenue, Lexington, MA, USA, 02421
Description
Translate Bio Inc is a clinical-stage mRNA therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction. The company is developing MRT5005, for the treatment of cystic fibrosis (CF) and MRT5201, for the treatment of ornithine transcarbamylase (OTC) deficiency.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 11.53
Equity-to-Asset 0.46
Debt-to-Equity 0.14
Debt-to-EBITDA 1.12
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 4.11
Distress
Grey
Safe
Beneish M-Score 3.05
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 44.47
9-Day RSI 45.39
14-Day RSI 43.34
6-1 Month Momentum % 53.41
12-1 Month Momentum % 168.61

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 8.8
Quick Ratio 8.8
Cash Ratio 8.19

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -20.3

Financials (Next Earnings Date:2022-11-05 Est.)

TBIO's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:TBIO

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 225.086
EPS (TTM) ($) 0.506
Beta 0
Volatility % 113.1
14-Day RSI 43.34
14-Day ATR ($) 0.295778
20-Day SMA ($) 37.4565
12-1 Month Momentum % 168.61
52-Week Range ($) 11.91 - 37.985
Shares Outstanding (Mil) 75.59

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Translate Bio Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More